Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A11334 | 30932777 | Int J Vitam Nutr Res | Ramadan fasting improves liver function and total cholesterol in patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11335 | 30932742 | OMICS | Novel Serum Biomarkers for Noninvasive Diagnosis and Screening of Nonalcoholic Fatty Liver Disease-Related Hepatic Fibrosis. | 2019 | Details |
| A11336 | 30931853 | Curr Pharm Des | Valproic Acid and the Liver Injury in Patients with Epilepsy: An Update. | 2019 | Details |
| A11337 | 30931596 | Orv Hetil | [Alcoholic liver disease: the roles of genetic-epigenetic factors and the effect of abstinence]. | 2019 | Details |
| A11338 | 30931410 | Comput Toxicol | Frequent Modulation of the Sterol Regulatory Element Binding Protein (SREBP) by Chemical Exposure in the Livers of Rats. | 2019 | Details |
| A11339 | 30931332 | Biomed Res Int | Role of Noncoding RNA in Development of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11340 | 30931080 | Oxid Med Cell Longev | Cherry Anthocyanins Regulate NAFLD by Promoting Autophagy Pathway. | 2019 | Details |
| A11341 | 30930223 | J Hepatol | The circadian clock and liver function in health and disease. | 2019 | Details |
| A11342 | 30929343 | Zhonghua Gan Zang Bing Za Zhi | [Addressing the cancer invasion in non-alcoholic steatohepatitis]. | 2019 | Details |
| A11343 | 30929342 | Zhonghua Gan Zang Bing Za Zhi | [Research progress of single-nucleotide polymorphism in theTM6SF2 rs58542926]. | 2019 | Details |
| A11344 | 30929337 | Zhonghua Gan Zang Bing Za Zhi | [Analysis of influencing factors and causes of death in elderly residents with non-alcoholic fatty liver disease]. | 2019 | Details |
| A11345 | 30928957 | BMJ Open | Dose-response association between physical activity and non-alcoholic fatty liver disease: a case-control study in a Chinese population. | 2019 | Details |
| A11346 | 30928918 | BMJ Open | Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials. | 2019 | Details |
| A11347 | 30928418 | Dig Liver Dis | Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11348 | 30927921 | Lipids Health Dis | The severity of rat liver injury by fructose and high fat depends on the degree of respiratory dysfunction and oxidative stress induced in mitochondria. | 2019 | Details |
| A11349 | 34485777 | Curr Opin Toxicol | Polychlorinated Biphenyls and Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11350 | 30927369 | Br J Pharmacol | Oral administration of a new HRI activator as a new strategy to improve high-fat-diet-induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21. | 2019 | Details |
| A11351 | 30927288 | Clin Transplant | The impact of post-transplant diabetes mellitus on liver transplant outcomes. | 2019 | Details |
| A11352 | 30926798 | Nat Commun | A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease. | 2019 | Details |
| A11353 | 30926171 | Biochem Biophys Res Commun | PEDF promotes nuclear degradation of ATGL through COP1. | 2019 | Details |
| A11354 | 30925684 | Int J Mol Sci | The Influence of Trehalose on Atherosclerosis and Hepatic Steatosis in Apolipoprotein E Knockout Mice. | 2019 | Details |
| A11355 | 30924946 | Hepatology | Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps. | 2019 | Details |
| A11356 | 30924602 | Liver Int | Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States. | 2019 | Details |
| A11357 | 30924429 | Proc Nutr Soc | From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis. | 2019 | Details |
| A11358 | 30923657 | PeerJ | Identification of key genes, pathways and potential therapeutic agents for liver fibrosis using an integrated bioinformatics analysis. | 2019 | Details |
| A11359 | 30923554 | Cell Mol Biol Lett | The Pro12Ala polymorphism in the PPAR-γ2 gene is not associated with an increased risk of NAFLD in Iranian patients with type 2 diabetes mellitus. | 2019 | Details |
| A11360 | 30922791 | Clin Nutr | Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: A population-based study of northern Iran. | 2019 | Details |
| A11362 | 30922067 | Cell Transplant | Association between Non-Alcoholic Fatty Liver Disease and Intracerebral Hemorrhage. | 2019 | Details |
| A11363 | 30921653 | Adv Med Sci | Can hepatokines be regarded as novel non-invasive serum biomarkers of intrahepatic lipid content in obese children? | 2019 | Details |
| A11364 | 30921449 | PLoS One | Combined effects of ambient particulate matter exposure and a high-fat diet on oxidative stress and steatohepatitis in mice. | 2019 | Details |
| A11365 | 30920975 | Eur J Gastroenterol Hepatol | Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial. | 2019 | Details |
| A11366 | 30920583 | Endocr Rev | The Liver-α-Cell Axis and Type 2 Diabetes. | 2019 | Details |
| A11368 | 30920415 | Am J Gastroenterol | Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation. | 2019 | Details |
| A11372 | 30919598 | J Diabetes Investig | Rho-associated, coiled-coil-containing protein kinase 1 as a new player in the regulation of hepatic lipogenesis. | 2019 | Details |
| A11373 | 30919338 | Adv Exp Med Biol | Circular RNAs as Potential Biomarkers and Therapeutic Targets for Metabolic Diseases. | 2019 | Details |
| A11374 | 30919335 | Adv Exp Med Biol | miRNA Regulation of Glucose and Lipid Metabolism in Relation to Diabetes and Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A11375 | 30919331 | Adv Exp Med Biol | Current Models of Fatty Liver Disease; New Insights, Therapeutic Targets and Interventions. | 2019 | Details |
| A11376 | 30919112 | Heart Vessels | High Fib4 index in patients with suspected NASH is associated with elevation of chymase-dependent angiotensin II-forming activity in circulating mononuclear leucocytes. | 2019 | Details |
| A11377 | 30918952 | Inflamm Bowel Dis | Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease. | 2019 | Details |
| A11378 | 30918873 | J Diabetes Metab Disord | Life-style-induced metabolic derangement and epigenetic changes promote diabetes and oxidative stress leading to NASH and atherosclerosis severity. | 2018 | Details |
| A11379 | 30918425 | World J Gastroenterol | Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. | 2019 | Details |
| A11380 | 30918325 | Lab Invest | Human relaxin-2 attenuates hepatic steatosis and fibrosis in mice with non-alcoholic fatty liver disease. | 2019 | Details |
| A11381 | 30918066 | J Lipid Res | PNPLA2 influences secretion of triglyceride-rich lipoproteins by human hepatoma cells. | 2019 | Details |
| A11382 | 30918065 | J Lipid Res | PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients. | 2019 | Details |
| A11383 | 30917662 | Rev Esp Enferm Dig | Characterizing specific subgroups in patients with NAFLD: overweight vs obese phenotype. | 2019 | Details |
| A11384 | 30917546 | Nutrients | Non-Alcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: Role of Circulating Branched-Chain Amino Acids. | 2019 | Details |
| A11385 | 30917489 | Int J Mol Sci | MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice. | 2019 | Details |
| A11386 | 30917157 | PLoS One | Peanut skin phenolic extract attenuates hyperglycemic responses in vivo and in vitro. | 2019 | Details |
| A11387 | 30916873 | Liver Int | Fibroblast growth factor 21 is independently associated with severe hepatic steatosis in non-obese HIV-infected patients. | 2019 | Details |
| A11389 | 30916169 | Arch Endocrinol Metab | Could semiquantitative analysis of real-time ultrasound elastography distinguish more liver parenchyma alterations of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome? | 2019 | Details |
| A11392 | 30915409 | Clin Exp Hepatol | Allopurinol potentiates the hepatoprotective effect of metformin and vitamin E in fructose-induced fatty liver in rats. | 2019 | Details |
| A11393 | 30915402 | Clin Exp Hepatol | Update on pathogenesis, diagnostics and therapy of nonalcoholic fatty liver disease in children. | 2019 | Details |
| A11394 | 30915401 | Clin Exp Hepatol | Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease. | 2019 | Details |
| A11395 | 30915371 | J Immunol Res | Immunoregulatory Effect of Koumine on Nonalcoholic Fatty Liver Disease Rats. | 2019 | Details |
| A11396 | 30914267 | J Hepatol | Macrophage p38α promotes nutritional steatohepatitis through M1 polarization. | 2019 | Details |
| A11397 | 30913263 | PLoS One | Non-invasive assessment of NAFLD as systemic disease-A machine learning perspective. | 2019 | Details |
| A11398 | 30912854 | Hepatology | Relationship Between PNPLA3 rs738409 Polymorphism and Decreased Kidney Function in Children With NAFLD. | 2019 | Details |
| A11399 | 30912337 | Endocrinol Metab (Seoul) | Implications of Mitochondrial Unfolded Protein Response and Mitokines: A Perspective on Fatty Liver Diseases. | 2019 | Details |
| A11400 | 30912307 | Physiol Rep | The long-term protective effects of neonatal administration of curcumin against nonalcoholic steatohepatitis in high-fructose-fed adolescent rats. | 2019 | Details |
| A11401 | 30912255 | Liver Int | Association of adipokines with hepatic steatosis and fibrosis in chronic hepatitis B patients on long-term nucleoside analogue. | 2019 | Details |
| A11402 | 30912099 | Semin Liver Dis | Genetics of Nonalcoholic Fatty Liver Disease: From Pathogenesis to Therapeutics. | 2019 | Details |
| A11403 | 30909521 | Cells | A New Targeted Lipidomics Approach Reveals Lipid Droplets in Liver, Muscle and Heart as a Repository for Diacylglycerol and Ceramide Species in Non-Alcoholic Fatty Liver. | 2019 | Details |
| A11404 | 30908822 | Intern Med J | Improving survival in patients with hepatocellular carcinoma related to chronic hepatitis C and B but not in those related to non-alcoholic steatohepatitis or alcoholic liver disease: a 20-year experience from a national programme. | 2019 | Details |
| A11405 | 30908678 | Hepatology | A 17-Beta-Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver Disease. | 2019 | Details |
| A11406 | 30908654 | J Cell Physiol | Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease. | 2019 | Details |
| A11407 | 30907181 | Scand J Gastroenterol | Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A11408 | 30907050 | Helicobacter | Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: A systematic review and meta-analysis of observational studies. | 2019 | Details |
| A11410 | 30906837 | Genes Dis | The methylenetetrahydrofolate reductase genotype 677CT and non-alcoholic fatty liver disease have a synergistic effect on the increasing homocysteine levels in subjects from Chongqing, China. | 2018 | Details |
| A11411 | 30905786 | Biochim Biophys Acta Mol Basis Dis | Chemokine (C-C motif) ligand 2 gene ablation protects low-density lipoprotein and paraoxonase-1 double deficient mice from liver injury, oxidative stress and inflammation. | 2019 | Details |
| A11412 | 30905785 | Biochim Biophys Acta Mol Basis Dis | Intestinal vitamin D receptor modulates lipid metabolism, adipose tissue inflammation and liver steatosis in obese mice. | 2019 | Details |
| A11413 | 30905315 | Adipocyte | Adipocytes as lipid sensors of oleic acid transport through a functional Caco-2/HT29-MTX intestinal barrier. | 2019 | Details |
| A11414 | 30905208 | Expert Rev Gastroenterol Hepatol | Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease. | 2019 | Details |
| A11415 | 30903305 | Eur J Pediatr | Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease. | 2019 | Details |
| A11417 | 30902670 | Lancet Gastroenterol Hepatol | Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. | 2019 | Details |
| A11420 | 30901929 | Nutrients | Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11421 | 30901317 | Rom J Intern Med | Non-alcoholic fatty pancreas disease - practices for clinicians. | 2019 | Details |
| A11422 | 30901032 | J Clin Endocrinol Metab | Dysregulation of the Splicing Machinery Is Associated to the Development of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11423 | 30901029 | Endocr Rev | Emerging Roles for Serotonin in Regulating Metabolism: New Implications for an Ancient Molecule. | 2019 | Details |
| A11424 | 30901028 | J Clin Endocrinol Metab | Patients With Aldolase B Deficiency Are Characterized by Increased Intrahepatic Triglyceride Content. | 2019 | Details |
| A11425 | 30900792 | BJU Int | The independent association of non-alcoholic fatty liver disease with lower urinary tract symptoms/benign prostatic hyperplasia and erectile function scores. | 2019 | Details |
| A11426 | 30899974 | Eur Radiol | Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis. | 2019 | Details |
| A11427 | 30899593 | J Adv Res | Repin1 deficiency in liver tissue alleviates NAFLD progression in mice. | 2018 | Details |
| A11428 | 30898698 | Gene | Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p. | 2019 | Details |
| A11429 | 30898592 | Sex Med Rev | Nonalcoholic Fatty Liver Disease, Male Sexual Dysfunction, and Infertility: Common Links, Common Problems. | 2019 | Details |
| A11430 | 30897538 | Biomed Pharmacother | Biological mechanisms and related natural modulators of liver X receptor in nonalcoholic fatty liver disease. | 2019 | Details |
| A11432 | 30896961 | Rev Esp Enferm Dig | Association between thymosin beta4 and non-alcoholic fatty liver disease. | 2019 | Details |
| A11433 | 30896960 | Rev Esp Enferm Dig | Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models. | 2019 | Details |
| A11434 | 30896957 | Rev Esp Enferm Dig | Bariatric and metabolic endoscopy in the handling of fatty liver disease. A new emerging approach? | 2019 | Details |
| A11435 | 30896956 | Rev Esp Enferm Dig | An assessment of bacterial overgrowth and translocation in the non-alcoholic fatty liver of patients with morbid obesity. | 2019 | Details |
| A11436 | 30896868 | Mol Med Rep | Hepatic miR‑215 target Rictor and modulation of hepatic insulin signalling in rats. | 2019 | Details |
| A11437 | 30896648 | Medicine (Baltimore) | A randomized controlled trial on the effectiveness of 8-week high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and health-related quality of life in diabetic obese patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11438 | 30896410 | Asia Pac J Clin Nutr | Utility of different indices in screening Chinese postmenopausal women for hepatic steatosis. | 2019 | Details |
| A11439 | 30895694 | Phytother Res | The clinical effects of purslane (Portulaca oleracea) seeds on metabolic profiles in patients with nonalcoholic fatty liver disease: A randomized controlled clinical trial. | 2019 | Details |
| A11440 | 30894137 | BMC Gastroenterol | The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience. | 2019 | Details |
| A11441 | 30893108 | Curr Opin Lipidol | Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell? | 2019 | Details |
| A11442 | 30893090 | Curr Opin Clin Nutr Metab Care | Sarcopenic obesity in fatty liver. | 2019 | Details |
| A11443 | 30892882 | J Agric Food Chem | Preventive Efficiency of Green Tea and Its Components on Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11444 | 30892820 | Diabetes Metab Res Rev | Independent markers of nonalcoholic fatty liver disease in a gentrifying population-based Chinese cohort. | 2019 | Details |
| A11445 | 30892481 | Sao Paulo Med J | Association of alanine aminotransferase concentration with cardiometabolic risk factors in children and adolescents: the CASPIAN-V cross-sectional study. | 2019 | Details |
| A11446 | 30891617 | J Mol Med (Berl) | Innate immune regulatory networks in hepatic lipid metabolism. | 2019 | Details |